tokens
sequence
tags
sequence
sentence_id
stringlengths
6
11
[ "Fifty", "-", "eight", "patients", "(", "78", "%", ")", "had", "normal", "renal", "tests", ",", "whereas", "16", "patients", "(", "22", "%", ")", "had", "renal", "abnormalities", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0 ]
BC5CDR-1628
[ "Two", "subsets", "of", "patients", "were", "identified", "from", "this", "latter", "group", ":", "the", "first", "included", "four", "patients", "(", "5", "%", "of", "the", "total", "population", ")", "who", "developed", "major", "toxicity", "resulting", "in", "Fanconi", "'", "s", "syndrome", "(", "TDFS", ")", ";", "and", "the", "second", "group", "included", "five", "patients", "with", "elevated", "beta", "2", "microglobulinuria", "and", "low", "phosphate", "reabsorption", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 2, 2, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1629
[ "Age", "-", "related", "changes", "in", "ultrasound", "production", "corresponded", "with", "changes", "in", "cardiovascular", "variables", ",", "including", "baseline", "cardiac", "rate", "and", "clonidine", "-", "induced", "bradycardia", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-163
[ "The", "remaining", "seven", "patients", "had", "isolated", "beta", "2", "microglobulinuria", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1630
[ "Severe", "toxicity", "was", "correlated", "with", "the", "higher", "cumulative", "dose", "of", "60", "g", "/", "m2", "of", "ifosfamide", ",", "a", "younger", "age", "(", "less", "than", "2", "1", "/", "2", "years", "old", ")", ",", "and", "a", "predominance", "of", "vesicoprostatic", "tumor", "involvement", "." ]
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
BC5CDR-1631
[ "This", "low", "percentage", "(", "5", "%", ")", "of", "TDFS", "must", "be", "evaluated", "with", "respect", "to", "the", "efficacy", "of", "ifosfamide", "in", "the", "treatment", "of", "mesenchymal", "tumors", "in", "children", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0 ]
BC5CDR-1632
[ "Progressive", "myopathy", "with", "up", "-", "regulation", "of", "MHC", "-", "I", "associated", "with", "statin", "therapy", "." ]
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1633
[ "Statins", "can", "cause", "a", "necrotizing", "myopathy", "and", "hyperCKaemia", "which", "is", "reversible", "on", "cessation", "of", "the", "drug", "." ]
[ 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1634
[ "What", "is", "less", "well", "known", "is", "a", "phenomenon", "whereby", "statins", "may", "induce", "a", "myopathy", ",", "which", "persists", "or", "may", "progress", "after", "stopping", "the", "drug", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1635
[ "We", "investigated", "the", "muscle", "pathology", "in", "8", "such", "cases", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1636
[ "All", "had", "myofibre", "necrosis", "but", "only", "3", "had", "an", "inflammatory", "infiltrate", "." ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1637
[ "In", "all", "cases", "there", "was", "diffuse", "or", "multifocal", "up", "-", "regulation", "of", "MHC", "-", "I", "expression", "even", "in", "non", "-", "necrotic", "fibres", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
BC5CDR-1638
[ "Progressive", "improvement", "occurred", "in", "7", "cases", "after", "commencement", "of", "prednisolone", "and", "methotrexate", ",", "and", "in", "one", "case", "spontaneously", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1639
[ "This", "experiment", "is", "discussed", "with", "regard", "to", "the", "hypothesis", "that", "ultrasound", "production", "is", "the", "acoustic", "by", "-", "product", "of", "a", "physiological", "maneuver", "that", "compensates", "for", "clonidine", "'", "s", "detrimental", "effects", "on", "cardiovascular", "function", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-164
[ "These", "observations", "suggest", "that", "statins", "may", "initiate", "an", "immune", "-", "mediated", "myopathy", "that", "persists", "after", "withdrawal", "of", "the", "drug", "and", "responds", "to", "immunosuppressive", "therapy", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1640
[ "The", "mechanism", "of", "this", "myopathy", "is", "uncertain", "but", "may", "involve", "the", "induction", "by", "statins", "of", "an", "endoplasmic", "reticulum", "stress", "response", "with", "associated", "up", "-", "regulation", "of", "MHC", "-", "I", "expression", "and", "antigen", "presentation", "by", "muscle", "fibres", "." ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1641
[ "Use", "of", "chromosome", "substitution", "strains", "to", "identify", "seizure", "susceptibility", "loci", "in", "mice", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
BC5CDR-1642
[ "Seizure", "susceptibility", "varies", "among", "inbred", "mouse", "strains", "." ]
[ 1, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1643
[ "Chromosome", "substitution", "strains", "(", "CSS", ")", ",", "in", "which", "a", "single", "chromosome", "from", "one", "inbred", "strain", "(", "donor", ")", "has", "been", "transferred", "onto", "a", "second", "strain", "(", "host", ")", "by", "repeated", "backcrossing", ",", "may", "be", "used", "to", "identify", "quantitative", "trait", "loci", "(", "QTLs", ")", "that", "contribute", "to", "seizure", "susceptibility", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
BC5CDR-1644
[ "QTLs", "for", "susceptibility", "to", "pilocarpine", "-", "induced", "seizures", ",", "a", "model", "of", "temporal", "lobe", "epilepsy", ",", "have", "not", "been", "reported", ",", "and", "CSS", "have", "not", "previously", "been", "used", "to", "localize", "seizure", "susceptibility", "genes", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
BC5CDR-1645
[ "We", "report", "QTLs", "identified", "using", "a", "B6", "(", "host", ")", "x", "A", "/", "J", "(", "donor", ")", "CSS", "panel", "to", "localize", "genes", "involved", "in", "susceptibility", "to", "pilocarpine", "-", "induced", "seizures", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1646
[ "Three", "hundred", "fifty", "-", "five", "adult", "male", "CSS", "mice", ",", "58", "B6", ",", "and", "39", "A", "/", "J", "were", "tested", "for", "susceptibility", "to", "pilocarpine", "-", "induced", "seizures", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1647
[ "Highest", "stage", "reached", "and", "latency", "to", "each", "stage", "were", "recorded", "for", "all", "mice", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1648
[ "B6", "mice", "were", "resistant", "to", "seizures", "and", "slower", "to", "reach", "stages", "compared", "to", "A", "/", "J", "mice", "." ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1649
[ "Recurrent", "use", "of", "newer", "oral", "contraceptives", "and", "the", "risk", "of", "venous", "thromboembolism", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0 ]
BC5CDR-165
[ "The", "CSS", "for", "Chromosomes", "10", "and", "18", "progressed", "to", "the", "most", "severe", "stages", ",", "diverging", "dramatically", "from", "the", "B6", "phenotype", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1650
[ "Latencies", "to", "stages", "were", "also", "significantly", "shorter", "for", "CSS10", "and", "CSS18", "mice", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1651
[ "CSS", "mapping", "suggests", "seizure", "susceptibility", "loci", "on", "mouse", "Chromosomes", "10", "and", "18", "." ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1652
[ "This", "approach", "provides", "a", "framework", "for", "identifying", "potentially", "novel", "homologous", "candidate", "genes", "for", "human", "temporal", "lobe", "epilepsy", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0 ]
BC5CDR-1653
[ "In", "vitro", "characterization", "of", "parasympathetic", "and", "sympathetic", "responses", "in", "cyclophosphamide", "-", "induced", "cystitis", "in", "the", "rat", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
BC5CDR-1654
[ "In", "cyclophosphamide", "-", "induced", "cystitis", "in", "the", "rat", ",", "detrusor", "function", "is", "impaired", "and", "the", "expression", "and", "effects", "of", "muscarinic", "receptors", "altered", "." ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1655
[ "Whether", "or", "not", "the", "neuronal", "transmission", "may", "be", "affected", "by", "cystitis", "was", "presently", "investigated", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
BC5CDR-1656
[ "Responses", "of", "urinary", "strip", "preparations", "from", "control", "and", "cyclophosphamide", "-", "pretreated", "rats", "to", "electrical", "field", "stimulation", "and", "to", "agonists", "were", "assessed", "in", "the", "absence", "and", "presence", "of", "muscarinic", ",", "adrenergic", "and", "purinergic", "receptor", "antagonists", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1657
[ "Generally", ",", "atropine", "reduced", "contractions", ",", "but", "in", "contrast", "to", "controls", ",", "it", "also", "reduced", "responses", "to", "low", "electrical", "field", "stimulation", "intensity", "(", "1", "-", "5", "Hz", ")", "in", "inflamed", "preparations", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1658
[ "In", "both", "types", ",", "purinoceptor", "desensitization", "with", "alpha", ",", "beta", "-", "methylene", "adenosine", "-", "5", "'", "-", "triphosphate", "(", "alpha", ",", "beta", "-", "meATP", ")", "caused", "further", "reductions", "at", "low", "frequencies", "(", "<", "10", "Hz", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1659
[ "The", "epidemiological", "studies", "that", "assessed", "the", "risk", "of", "venous", "thromboembolism", "(", "VTE", ")", "associated", "with", "newer", "oral", "contraceptives", "(", "OC", ")", "did", "not", "distinguish", "between", "patterns", "of", "OC", "use", ",", "namely", "first", "-", "time", "users", ",", "repeaters", "and", "switchers", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-166
[ "The", "muscarinic", "receptor", "antagonists", "atropine", ",", "4", "-", "diphenylacetoxy", "-", "N", "-", "methylpiperidine", "(", "4", "-", "DAMP", ")", "(", "'", "M", "(", "1", ")", "/", "M", "(", "3", ")", "/", "M", "(", "5", ")", "-", "selective", "'", ")", ",", "methoctramine", "(", "'", "M", "(", "2", ")", "-", "selective", "'", ")", "and", "pirenzepine", "(", "'", "M", "(", "1", ")", "-", "selective", "'", ")", "antagonized", "the", "tonic", "component", "of", "the", "electrical", "field", "stimulation", "-", "evoked", "contractile", "response", "more", "potently", "than", "the", "phasic", "component", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1660
[ "4", "-", "DAMP", "inhibited", "the", "tonic", "contractions", "in", "controls", "more", "potently", "than", "methoctramine", "and", "pirenzepine", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1661
[ "In", "inflamed", "preparations", ",", "the", "muscarinic", "receptor", "antagonism", "on", "the", "phasic", "component", "of", "the", "electrical", "field", "stimulation", "-", "evoked", "contraction", "was", "decreased", "and", "the", "pirenzepine", "and", "4", "-", "DAMP", "antagonism", "on", "the", "tonic", "component", "was", "much", "less", "efficient", "than", "in", "controls", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1662
[ "In", "contrast", "to", "controls", ",", "methoctramine", "increased", "-", "-", "instead", "of", "decreased", "-", "-", "the", "tonic", "responses", "at", "high", "frequencies", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1663
[ "While", "contractions", "to", "carbachol", "and", "ATP", "were", "the", "same", "in", "inflamed", "and", "in", "control", "strips", "when", "related", "to", "a", "reference", "potassium", "response", ",", "isoprenaline", "-", "induced", "relaxations", "were", "smaller", "in", "inflamed", "strips", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1664
[ "Thus", ",", "in", "cystitis", "substantial", "changes", "of", "the", "efferent", "functional", "responses", "occur", "." ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1665
[ "While", "postjunctional", "beta", "-", "adrenoceptor", "-", "mediated", "relaxations", "are", "reduced", ",", "effects", "by", "prejunctional", "inhibitory", "muscarinic", "receptors", "may", "be", "increased", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1666
[ "Direct", "inhibition", "of", "cardiac", "hyperpolarization", "-", "activated", "cyclic", "nucleotide", "-", "gated", "pacemaker", "channels", "by", "clonidine", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1667
[ "BACKGROUND", ":", "Inhibition", "of", "cardiac", "sympathetic", "tone", "represents", "an", "important", "strategy", "for", "treatment", "of", "cardiovascular", "disease", ",", "including", "arrhythmia", ",", "coronary", "heart", "disease", ",", "and", "chronic", "heart", "failure", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 1, 0, 1, 2, 2, 0, 0, 0, 1, 2, 0 ]
BC5CDR-1668
[ "Activation", "of", "presynaptic", "alpha2", "-", "adrenoceptors", "is", "the", "most", "widely", "accepted", "mechanism", "of", "action", "of", "the", "antisympathetic", "drug", "clonidine", ";", "however", ",", "other", "target", "proteins", "have", "been", "postulated", "to", "contribute", "to", "the", "in", "vivo", "actions", "of", "clonidine", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1669
[ "Data", "from", "a", "Transnational", "case", "-", "control", "study", "were", "used", "to", "assess", "the", "risk", "of", "VTE", "for", "the", "latter", "patterns", "of", "use", ",", "while", "accounting", "for", "duration", "of", "use", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-167
[ "METHODS", "AND", "RESULTS", ":", "To", "test", "whether", "clonidine", "elicits", "pharmacological", "effects", "independent", "of", "alpha2", "-", "adrenoceptors", ",", "we", "have", "generated", "mice", "with", "a", "targeted", "deletion", "of", "all", "3", "alpha2", "-", "adrenoceptor", "subtypes", "(", "alpha2ABC", "-", "/", "-", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1670
[ "Alpha2ABC", "-", "/", "-", "mice", "were", "completely", "unresponsive", "to", "the", "analgesic", "and", "hypnotic", "effects", "of", "clonidine", ";", "however", ",", "clonidine", "significantly", "lowered", "heart", "rate", "in", "alpha2ABC", "-", "/", "-", "mice", "by", "up", "to", "150", "bpm", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1671
[ "Clonidine", "-", "induced", "bradycardia", "in", "conscious", "alpha2ABC", "-", "/", "-", "mice", "was", "32", ".", "3", "%", "(", "10", "microg", "/", "kg", ")", "and", "26", ".", "6", "%", "(", "100", "microg", "/", "kg", ")", "of", "the", "effect", "in", "wild", "-", "type", "mice", "." ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1672
[ "A", "similar", "bradycardic", "effect", "of", "clonidine", "was", "observed", "in", "isolated", "spontaneously", "beating", "right", "atria", "from", "alpha2ABC", "-", "knockout", "and", "wild", "-", "type", "mice", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1673
[ "Clonidine", "inhibited", "the", "native", "pacemaker", "current", "(", "I", "(", "f", ")", ")", "in", "isolated", "sinoatrial", "node", "pacemaker", "cells", "and", "the", "I", "(", "f", ")", "-", "generating", "hyperpolarization", "-", "activated", "cyclic", "nucleotide", "-", "gated", "(", "HCN", ")", "2", "and", "HCN4", "channels", "in", "transfected", "HEK293", "cells", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1674
[ "As", "a", "consequence", "of", "blocking", "I", "(", "f", ")", ",", "clonidine", "reduced", "the", "slope", "of", "the", "diastolic", "depolarization", "and", "the", "frequency", "of", "pacemaker", "potentials", "in", "sinoatrial", "node", "cells", "from", "wild", "-", "type", "and", "alpha2ABC", "-", "knockout", "mice", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1675
[ "CONCLUSIONS", ":", "Direct", "inhibition", "of", "cardiac", "HCN", "pacemaker", "channels", "contributes", "to", "the", "bradycardic", "effects", "of", "clonidine", "gene", "-", "targeted", "mice", "in", "vivo", ",", "and", "thus", ",", "clonidine", "-", "like", "drugs", "represent", "novel", "structures", "for", "future", "HCN", "channel", "inhibitors", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1676
[ "Granulomatous", "hepatitis", "due", "to", "combination", "of", "amoxicillin", "and", "clavulanic", "acid", "." ]
[ 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1677
[ "We", "report", "the", "case", "of", "a", "patient", "with", "amoxicillin", "-", "clavulanic", "acid", "-", "induced", "hepatitis", "with", "histologic", "multiple", "granulomas", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0 ]
BC5CDR-1678
[ "This", "type", "of", "lesion", "broadens", "the", "spectrum", "of", "liver", "injury", "due", "to", "this", "drug", "combination", ",", "mainly", "represented", "by", "a", "benign", "cholestatic", "syndrome", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0 ]
BC5CDR-1679
[ "Over", "the", "period", "1993", "-", "1996", ",", "551", "cases", "of", "VTE", "were", "identified", "in", "Germany", "and", "the", "UK", "along", "with", "2066", "controls", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-168
[ "The", "association", "of", "granulomas", "and", "eosinophilia", "favor", "an", "immunoallergic", "mechanism", "." ]
[ 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0 ]
BC5CDR-1680
[ "As", "penicillin", "derivatives", "and", "amoxicillin", "alone", "are", "known", "to", "induce", "such", "types", "of", "lesions", ",", "the", "amoxicillin", "component", ",", "with", "or", "without", "a", "potentiating", "effect", "of", "clavulanic", "acid", ",", "might", "have", "a", "major", "role", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1681
[ "Dobutamine", "stress", "echocardiography", ":", "a", "sensitive", "indicator", "of", "diminished", "myocardial", "function", "in", "asymptomatic", "doxorubicin", "-", "treated", "long", "-", "term", "survivors", "of", "childhood", "cancer", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1682
[ "Doxorubicin", "is", "an", "effective", "anticancer", "chemotherapeutic", "agent", "known", "to", "cause", "acute", "and", "chronic", "cardiomyopathy", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1683
[ "To", "develop", "a", "more", "sensitive", "echocardiographic", "screening", "test", "for", "cardiac", "damage", "due", "to", "doxorubicin", ",", "a", "cohort", "study", "was", "performed", "using", "dobutamine", "infusion", "to", "differentiate", "asymptomatic", "long", "-", "term", "survivors", "of", "childhood", "cancer", "treated", "with", "doxorubicin", "from", "healthy", "control", "subjects", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1684
[ "Echocardiographic", "data", "from", "the", "experimental", "group", "of", "21", "patients", "(", "mean", "age", "16", "+", "/", "-", "5", "years", ")", "treated", "from", "1", ".", "6", "to", "14", ".", "3", "years", "(", "median", "5", ".", "3", ")", "before", "this", "study", "with", "27", "to", "532", "mg", "/", "m2", "of", "doxorubicin", "(", "mean", "196", ")", "were", "compared", "with", "echocardiographic", "data", "from", "12", "normal", "age", "-", "matched", "control", "subjects", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1685
[ "Graded", "dobutamine", "infusions", "of", "0", ".", "5", ",", "2", ".", "5", ",", "5", "and", "10", "micrograms", "/", "kg", "per", "min", "were", "administered", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1686
[ "Echocardiographic", "Doppler", "studies", "were", "performed", "before", "infusion", "and", "after", "15", "min", "of", "infusion", "at", "each", "rate", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1687
[ "Dobutamine", "infusion", "at", "10", "micrograms", "/", "kg", "per", "min", "was", "discontinued", "after", "six", "studies", "secondary", "to", "a", "50", "%", "incidence", "rate", "of", "adverse", "symptoms", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1688
[ "The", "most", "important", "findings", "were", "that", "compared", "with", "values", "in", "control", "subjects", ",", "end", "-", "systolic", "left", "ventricular", "posterior", "wall", "dimension", "and", "percent", "of", "left", "ventricular", "posterior", "wall", "thickening", "in", "doxorubicin", "-", "treated", "patients", "were", "decreased", "at", "baseline", "study", "and", "these", "findings", "were", "more", "clearly", "delineated", "with", "dobutamine", "stimulation", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1689
[ "Totals", "of", "128", "cases", "and", "650", "controls", "were", "analysed", "for", "repeat", "use", "and", "135", "cases", "and", "622", "controls", "for", "switching", "patterns", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-169
[ "End", "-", "systolic", "left", "ventricular", "posterior", "wall", "dimension", "at", "baseline", "for", "the", "doxorubicin", "-", "treated", "group", "was", "11", "+", "/", "-", "1", ".", "9", "mm", "versus", "13", ".", "1", "+", "/", "-", "1", ".", "5", "mm", "for", "control", "subjects", "(", "p", "less", "than", "0", ".", "01", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1690
[ "End", "-", "systolic", "left", "ventricular", "posterior", "wall", "dimension", "at", "the", "5", "-", "micrograms", "/", "kg", "per", "min", "dobutamine", "infusion", "for", "the", "doxorubicin", "-", "treated", "group", "was", "14", ".", "1", "+", "/", "-", "2", ".", "4", "mm", "versus", "19", ".", "3", "+", "/", "-", "2", ".", "6", "mm", "for", "control", "subjects", "(", "p", "less", "than", "0", ".", "01", ")", ".", "(", "ABSTRACT", "TRUNCATED", "AT", "250", "WORDS", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1691
[ "Influence", "of", "smoking", "on", "developing", "cochlea", "." ]
[ 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1692
[ "Does", "smoking", "during", "pregnancy", "affect", "the", "amplitudes", "of", "transient", "evoked", "otoacoustic", "emissions", "in", "newborns", "?" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1693
[ "OBJECTIVE", ":", "Maternal", "tobacco", "smoking", "has", "negative", "effects", "on", "fetal", "growth", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1694
[ "The", "influence", "of", "smoking", "during", "pregnancy", "on", "the", "developing", "cochlea", "has", "not", "been", "estimated", ",", "although", "smoking", "has", "been", "positively", "associated", "with", "hearing", "loss", "in", "adults", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0 ]
BC5CDR-1695
[ "The", "objective", "of", "this", "study", "was", "to", "determine", "the", "effects", "of", "maternal", "smoking", "on", "transient", "evoked", "otoacoustic", "emissions", "(", "TEOAEs", ")", "of", "healthy", "neonates", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1696
[ "METHODS", ":", "This", "study", "was", "undertaken", "as", "part", "of", "neonatal", "screening", "for", "hearing", "impairment", "and", "involved", "both", "ears", "of", "200", "newborns", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1697
[ "Newborns", "whose", "mothers", "reported", "smoking", "during", "pregnancy", "(", "n", "=", "200", "ears", ")", "were", "compared", "to", "a", "control", "group", "of", "newborns", "(", "n", "=", "200", "ears", ")", ",", "whose", "mothers", "were", "non", "-", "smokers", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1698
[ "Exposure", "to", "tobacco", "was", "characterized", "as", "low", "(", "<", "5", "cigarettes", "per", "day", ",", "n", "=", "88", "ears", ")", ",", "moderate", "(", "5", "<", "or", "=", "cigarettes", "per", "day", "<", "10", ",", "n", "=", "76", ")", "or", "high", "(", ">", "or", "=", "10", "cigarettes", "per", "day", ",", "n", "=", "36", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1699
[ "Effects", "of", "tetrandrine", "and", "fangchinoline", "on", "experimental", "thrombosis", "in", "mice", "and", "human", "platelet", "aggregation", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 2, 0 ]
BC5CDR-17
[ "The", "adjusted", "rate", "ratio", "of", "VTE", "for", "repeat", "users", "of", "third", "generation", "OC", "was", "0", ".", "6", "(", "95", "%", "CI", ":", "0", ".", "3", "-", "1", ".", "2", ")", "relative", "to", "repeat", "users", "of", "second", "generation", "pills", ",", "whereas", "it", "was", "1", ".", "3", "(", "95", "%", "CI", ":", "0", ".", "7", "-", "2", ".", "4", ")", "for", "switchers", "from", "second", "to", "third", "generation", "pills", "relative", "to", "switchers", "from", "third", "to", "second", "generation", "pills", "." ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-170
[ "RESULTS", ":", "In", "exposed", "neonates", ",", "TEOAEs", "mean", "response", "(", "across", "frequency", ")", "and", "mean", "amplitude", "at", "4000Hz", "was", "significantly", "lower", "than", "in", "non", "-", "exposed", "neonates", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1700
[ "Comparisons", "between", "exposed", "newborns", "'", "subgroups", "revealed", "no", "significant", "differences", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1701
[ "However", ",", "by", "comparing", "each", "subgroup", "to", "control", "group", ",", "we", "found", "statistically", "significant", "decreases", "of", "TEOAEs", "amplitudes", "at", "4000Hz", "for", "all", "three", "groups", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1702
[ "Mean", "TEOAEs", "responses", "of", "highly", "exposed", "newborns", "were", "also", "significantly", "lower", "in", "comparison", "to", "our", "control", "group", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1703
[ "CONCLUSION", ":", "In", "utero", ",", "exposure", "to", "tobacco", "smoking", "seems", "to", "have", "a", "small", "impact", "on", "outer", "hair", "cells", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1704
[ "These", "effects", "seem", "to", "be", "equally", "true", "for", "all", "exposed", "newborns", ",", "regardless", "of", "the", "degree", "of", "exposure", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1705
[ "Further", "studies", "are", "needed", "in", "order", "to", "establish", "a", "potential", "negative", "effect", "of", "maternal", "smoking", "on", "the", "neonate", "'", "s", "hearing", "acuity", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1706
[ "Simvastatin", "-", "induced", "bilateral", "leg", "compartment", "syndrome", "and", "myonecrosis", "associated", "with", "hypothyroidism", "." ]
[ 0, 0, 0, 0, 0, 1, 2, 0, 1, 0, 0, 1, 0 ]
BC5CDR-1707
[ "A", "54", "-", "year", "-", "old", "hypothyroid", "male", "taking", "thyroxine", "and", "simvastatin", "presented", "with", "bilateral", "leg", "compartment", "syndrome", "and", "myonecrosis", "." ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 0 ]
BC5CDR-1708
[ "Urgent", "fasciotomies", "were", "performed", "and", "the", "patient", "made", "an", "uneventful", "recovery", "with", "the", "withdrawal", "of", "simvastatin", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1709
[ "We", "conclude", "that", "second", "and", "third", "generation", "agents", "are", "associated", "with", "equivalent", "risks", "of", "VTE", "when", "the", "same", "agent", "is", "used", "repeatedly", "after", "interruption", "periods", "or", "when", "users", "are", "switched", "between", "the", "two", "generations", "of", "pills", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-171
[ "It", "is", "likely", "that", "this", "complication", "will", "be", "seen", "more", "often", "with", "the", "increased", "worldwide", "use", "of", "this", "drug", "and", "its", "approval", "for", "all", "arteriopathic", "patients", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
BC5CDR-1710
[ "Neuroinflammation", "and", "behavioral", "abnormalities", "after", "neonatal", "terbutaline", "treatment", "in", "rats", ":", "implications", "for", "autism", "." ]
[ 1, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1711
[ "Autism", "is", "a", "neurodevelopmental", "disorder", "presenting", "before", "3", "years", "of", "age", "with", "deficits", "in", "communication", "and", "social", "skills", "and", "repetitive", "behaviors", "." ]
[ 1, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 0, 1, 2, 0 ]
BC5CDR-1712
[ "In", "addition", "to", "genetic", "influences", ",", "recent", "studies", "suggest", "that", "prenatal", "drug", "or", "chemical", "exposures", "are", "risk", "factors", "for", "autism", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1713
[ "Terbutaline", ",", "a", "beta2", "-", "adrenoceptor", "agonist", "used", "to", "arrest", "preterm", "labor", ",", "has", "been", "associated", "with", "increased", "concordance", "for", "autism", "in", "dizygotic", "twins", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
BC5CDR-1714
[ "We", "studied", "the", "effects", "of", "terbutaline", "on", "microglial", "activation", "in", "different", "brain", "regions", "and", "behavioral", "outcomes", "in", "developing", "rats", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1715
[ "Newborn", "rats", "were", "given", "terbutaline", "(", "10", "mg", "/", "kg", ")", "daily", "on", "postnatal", "days", "(", "PN", ")", "2", "to", "5", "or", "PN", "11", "to", "14", "and", "examined", "24", "h", "after", "the", "last", "dose", "and", "at", "PN", "30", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1716
[ "Immunohistochemical", "studies", "showed", "that", "administration", "of", "terbutaline", "on", "PN", "2", "to", "5", "produced", "a", "robust", "increase", "in", "microglial", "activation", "on", "PN", "30", "in", "the", "cerebral", "cortex", ",", "as", "well", "as", "in", "cerebellar", "and", "cerebrocortical", "white", "matter", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1717